CPT1A and glioblastoma: High expression of CPT1A not only enhances radiotherapy resistance in GBM tumor cells, but also enhances immune escape of macrophages through CD47, suggesting CPT1A as a novel strategy for the treatment of recurrent GBM multiforme.